Biotechnology
Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
SYDNEY, Sept. 22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with Dana-Farber Cancer Institute (DFCI) inthe United States, to investigate the use of...
2020-09-22 09:21
7621
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply
INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Pla...
2020-09-22 07:00
12630
PharmAbcine expands partnership with Samsung Biologics for PMC-403
DAEJEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Samsung Biologics (KRX: 207940.KS) for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate to treat neovascular ...
2020-09-21 20:00
1595
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or "Company") announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been successfu...
2020-09-21 10:35
2326
Apis Partners leads US$15 million investment in Prenetics
* Investment will go into game-changing rapid COVID-19 test, highly accurate, results in 15-30 minutes, no lab required, low-cost. In discussions with Governments globally. * Enabling Travel Bubble: Prenetics, Cathay Pacific to launch pilot in October 2020 from HKG to LHR with The Commons Pro...
2020-09-18 08:00
5776
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.
NANJING, China, Sept. 17, 2020 /PRNewswire/ -- On September 16th, 2020, GenScript ProBio and REMD Biotherapeutics Inc. (REMD) announced that REMD has licensed a bispecific antibody derived from the Single-domain antibody fused to Monoclonal Ab (SMAB) platform developed by GenScript ProBio. REMD i...
2020-09-17 22:00
2076
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma"), a Viva Biotech Portfolio Company, has reached an agreement for the acquisition of its oral PCSK9 program by AstraZeneca. Dogma will receive upfront as well as downstream payments linked to global regulatory and commerc...
2020-09-17 20:25
4024
Turkish Student Received Full Scholarship to Pursue Dream at The University of Hong Kong
ISTANBUL, Sept. 17, 2020 /PRNewswire/ -- The University of Hong Kong (HKU) established the HKU Scholarship for Future Leaders in the 2019/20 academic year to support talented students from developing countries to pursue their dreams at HKU. Applications were received from students inGhana, Madaga...
2020-09-17 20:00
1998
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020
HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...
2020-09-17 19:00
17086
Samsung Biologics signs development agreement with Panolos for solid tumor treatment
INCHEON, South Korea, Sept. 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors. Under this agreement, Samsung Biologics will provide a full scope of its developm...
2020-09-17 08:43
2435
Less is more: Novel algorithm automatically removes poor-quality data to improve AI scalability
SAN FRANCISCO, Sept. 15, 2020 /PRNewswire/ -- AI Healthcare company Presagen
has developed a novel technique that is able to automatically clean
poor-quality data needed to train scalable and reliable Artificial Intelligence
products.
2020-09-16 22:50
1798
Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy
SUZHOU, China and HANGZHOU, China, Sept. 15, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company, today announced success in scaling up the continuous perfusion process to 200L and completion of GMP production of a bispecific antibody for a Phase 1 clinical study. "This is an impo...
2020-09-15 23:00
1584
Innatoss Laboratories Launches Neutralizing Antibody Public Testing Service for SARS-CoV-2 in Europe using GenScript's cPass™ kit
LEIDEN, Netherlands and OSS, Netherlands and PISCATAWAY, New Jersey, Sept. 15,
2020 /PRNewswire/ -- Innatoss Laboratories
2020-09-15 17:30
3792
CBC Continues Strong Momentum and Reaches Major Milestones Across Healthcare Investment Platforms
SHANGHAI, Sept. 15, 2020 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, announced three major milestones across three of its healthcare investment platforms in September, underscoring CBC's strong momentum amid an evolving market. This includes NiKang Therapeutics' ("...
2020-09-15 12:17
2605
Standigm Partners with Excelra for GOSTAR to Enhance its AI-driven Drug Discovery Process
HYDERABAD, India and SEOUL, South Korea, Sept. 15, 2020 /PRNewswire/ -- Excelra
2020-09-15 10:00
3256
Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-09-15 03:41
3420
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020
DAEJEON, South Korea, Sept. 14, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) today announced positive data from its two combination trials of olinvacimab, its leading clinical candidate in oncology, with MSD's pembrolizumab at the 13th Annual Meeting of the Korean Society of Medical O...
2020-09-14 20:00
1546
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...
2020-09-14 08:30
3416
Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...
2020-09-14 08:17
3388
Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting
LONDON, Sept. 12, 2020 /PRNewswire/ -- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selectively Synergize...
2020-09-12 05:00
6152
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 313 media titles]
2024-05-15 12:00
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 289 media titles]
2024-05-09 11:00
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
[Picked up by 283 media titles]
2024-05-09 10:50
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
2024-05-09 11:00
12145
Cision's 2024 State of the Media Report: Journalists Battle Misinformation, Embrace Data, and Seek PR Partnership
2024-05-09 10:00
7679
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
2024-05-09 10:50
7422
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
6754
